BioHealth News Archive
TEDCO reaches ‘dramatic crossroads,’ taking on 5 times more venture responsibility – Baltimore Business Journal
Maryland Technology Development Corp.’s new board chair, Newt Fowler, is stepping in as the investment agency’s responsibility grows five-fold. TEDCO this year will take…
Read MoreSilver Spring-based United Therapeutics gets boost from new drug – Washington Business Journal
Silver Spring-based United Therapeutics' quarterly sales got a boost from its newest treatment for pulmonary arterial hypertension, while higher research and development costs, and…
Read MoreMedImmune Embraces Translational Sciences – Cambridge News
The term 'translational sciences' means different things to different people. For MedImmune, the global biologics research and development arm of AstraZeneca, the term refers…
Read MoreTEDCO board names new officers – Baltimore Business Journal
Newt Fowler, a longtime advisor and business planner for Baltimore entrepreneurs and investors, has been named chair of the Maryland Technology Development Corp. Fowler,…
Read MoreNIST Draws up Guidelines for Protecting Medical Patient Data on Mobile Devices – Nextgov.com
The federal government is attempting to ensure that doctors don't inadvertently compromise patient data when they use smartphones to access electronic health records. The National Institutes…
Read MoreTop 15 Corporate Venture Funds – GEN
The shift from fully integrated pharmaceutical companies (FIPCOs) to virtually integrated pharma companies (VIPCOs) has made biopharmas more reliant on external R&D. Often, that…
Read MoreBaxalta completes Oncaspar portfolio acquisition from Sigma-Tau Finanziaria
Baxalta Incorporated, a $6 billion global biopharmaceutical leader dedicated to delivering transformative therapies to patients with orphan diseases and underserved conditions, has completed the…
Read MoreInformation Session: Relevant Health – Hosted by BHI
Wednesday, August 5, 2015 from 5:00 PM to 7:00 PM (EDT) The Washington DC region is part of an east coast corridor rich in…
Read MoreMedimmune, Sheffield University to research in cell factory technology – Pharmaceutical Business Review
AstraZeneca's global biologics R&D arm MedImmune has entered into a five-year multi-project research collaboration with the University of Sheffield to carry out breakthrough research…
Read MoreJohns Hopkins University leads the top 5 employers in Greater Baltimore – Baltimore Business Journal
Johns Hopkins University tops the list of private, non-government employers in the Baltimore region, although three of the top five Baltimore-area employers are health…
Read MoreMedImmune partners with the University of Sheffield to generate innovations in cell factory engineering science | More News | News Channels
MedImmune, the global biologics research and development arm of AstraZeneca, and the University of Sheffield announced today that they have entered into a multi-project…
Read MoreConnecticut bioscience fund widens eligibility – Westfair Communications
Bioscience companies up to 7 years old can now apply for state funding that was formerly available only to younger companies. BioInnovation Connecticut, managed…
Read MoreTherapeutic Financing Rounds in 2015: Gene Therapy Outpaces Antibodies in Early Stage Investment | NEXT PHASE
It is no secret that 2015 has been a highly active year for deal-making in the life science space. However, what is often overlooked…
Read MoreThe Venture Funding Boom In Biotech: A Few Things It’s Not
Venture-backed biotechs continue their blistering pace of funding. According to the latest MoneyTree Report from PricewaterhouseCoopers (PwC) and the National Venture Capital Association (NVCA), with data from Thomson…
Read MoreBuilding the Health Tech Capital Tickets, Washington – Hosted by Relevant Health
Thursday, July 30, 2015 from 6:30 PM to 8:30 PM (EDT) Washington, DC The Washington DC region is part of an east coast corridor…
Read More